AveXis, Inc. 3 SEC Filings

Filed On	Filing
15 May 2018	Form 3: Novartis Ag, 10% owner Holds 36,816,476 shares of Common Stock, par value $0.0001
20 Oct 2017	Form 3: Donenberg Phillip B., Chief Financial Officer
01 Jun 2017	Form 3: Siffert Joao Md, Director Holds 0 shares of Common Stock
18 Apr 2017	Form 3: Smith Lori J., SVP-Chief Human Resource Off. Holds 0 shares of Common Stock
23 Mar 2017	Form 3: Session R.a. Ii, Sr. VP, Corp Strategy Holds 0 shares of Common Stock
15 Feb 2017	Form 3: Modi Rick, Chief Business Officer Holds 0 shares of Common Stock
07 Jul 2016	Form 3: Johannesen Michael, General Counsel Holds 0 shares of Common Stock
19 Feb 2016	Form 3: Deerfield PARTNERS, Lp, 10% owner and 1 other Holds 88,000 shares of Common Stock
10 Feb 2016	Form 3: Flynn James E, Director and 5 others Holds 131,911 shares of Common Stock
10 Feb 2016	Form 3: Welch Daniel G, Director Holds 0 shares of Common Stock
10 Feb 2016	Form 3: Verwiel Frank, Director Holds 0 shares of Common Stock
10 Feb 2016	Form 3: Koh Bong Y, Director Holds 517,499 shares of Common Stock
10 Feb 2016	Form 3: Nuechterlein Carole, Director Holds 0 shares of Common Stock
10 Feb 2016	Form 3: Leff Jonathan S, Director Holds 0 shares of Common Stock
10 Feb 2016	Form 3: Manning Paul B, Director and 1 other Holds 219,177 shares of Common Stock
10 Feb 2016	Form 3: Kearney Terrence C, Director Holds 0 shares of Common Stock
10 Feb 2016	Form 3: Knudten Andrew F., SrVP/Manufacture&Supply Chain Holds 0 shares of Common Stock
10 Feb 2016	Form 3: Litalien James J, SrVP/Chief Reg&Quality Officer Holds 0 shares of Common Stock
10 Feb 2016	Form 3: Nagendran Sukumar, Sr. VP & Chief Medical Officer Holds 0 shares of Common Stock
10 Feb 2016	Form 3: Dee Thomas J., Sr. VP & CFO Holds 0 shares of Common Stock

Comments